Indium (In111) Chloride Curium Netherlands (Indium (111in))

Indium‑111 chloride emits gamma photons that are detected by a gamma camera. Once injected, it binds to plasma proteins and is taken up by circulating leukocytes or accumulates in tissues with increased vascular permeability. This selective localization creates a radiation signal that highlights pathological sites such as infections, inflammatory lesions, or tumors.

The administered activity of Indium (In111) Chloride is determined by the prescribing physician based on the specific diagnostic indication, patient weight, and imaging protocol. Dosage is individualized and must follow local regulatory and radiation safety guidelines; it is not a fixed over‑the‑counter amount.

The safety of Indium (In111) Chloride in pregnancy and lactation has not been established. Because it involves ionizing radiation, it should be avoided unless the diagnostic benefit clearly outweighs the potential fetal or infant risk. Breastfeeding mothers should discontinue nursing for an appropriate period after administration, as advised by a radiation safety specialist.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indium‑111 chloride offers a relatively long half‑life (≈2.8 days) and gamma emissions suitable for high‑resolution imaging, making it advantageous for delayed imaging of infection or leukocyte labeling. Compared with technetium‑99m agents, it provides later time‑point imaging but involves higher radiation dose. Choice of agent depends on the clinical question, required imaging window, and availability.

Indium (In111) Chloride should be stored at 2‑8 °C in its original container, protected from light, and must not be frozen or shaken. The product is supplied in a shielded container to reduce radiation exposure. Follow local radiation safety and pharmacy handling protocols when preparing and administering the dose.

The radiopharmaceutical is administered intravenously as a sterile solution for injection. The prescribed activity is drawn into a shielded syringe and injected under aseptic conditions. After injection, the patient may be monitored briefly for any immediate reactions before proceeding with the planned imaging procedure.

Serious risks include radiation‑induced tissue injury, severe allergic reactions (anaphylaxis), significant hypotension, and potential hematologic toxicity with high cumulative doses. Patients should be screened for hypersensitivity, and radiation protection measures must be observed to minimize exposure to staff and surrounding individuals.

Indium (In111) Chloride is contraindicated in patients with known severe hypersensitivity to the product or its components, in pregnant women unless absolutely necessary, and in breastfeeding mothers who cannot discontinue nursing for the recommended period. Caution is also advised for individuals with severe renal impairment or those receiving conflicting radiopharmaceuticals.